Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
it would hold no dramas, but thats a poor choice in esters imo. what is ur pin schedule for that blend?
tren A would be more suitable as its a short ester
Who cares if it holds if a particular mixture is of limited anabolic benefit.
Blends of esters or parent compounds, are rarely used in medical practice and for good reason, the disadvantages outweigh the advantages.
And the mixing of two 19-nor compounds is a classic example
of what I’m referring to.
To that end many UGL offer blended products to enhance SALES, nothing more or less.
And bc of the challenges posed when AAS with different solubilities are mixed, I wouldn’t be surprised if a single compound is what MOST receive in the mail.
Who cares if it holds if a particular mixture is of limited anabolic benefit.
Blends of esters or parent compounds, are rarely used in medical practice and for good reason, the disadvantages outweigh the advantages.
And the mixing of two 19-nor compounds is a classic example
of what I’m referring to.
To that end many UGL offer blended products to enhance SALES, nothing more or less.
And bc of the challenges posed when AAS with different solubilities are mixed, I wouldn’t be surprised if a single compound is what MOST receive in the mail.
First since the raw source is somewhere in China there’s no telling what is being mixed, the ester usef or their concentration, UNLESS analytical testing was conducted.
Second the risk of contamination increases each time a raw is toyed with
Third - there’s no way to “undo” a mixture and that has several disadvantages such as KNOWING which adverse effects are due to what compound
Bla, bla, bla
So what about the most frequently cited rationale for combining AAS, a reduction in
pinning frequency, NOPE bc the half lives of all but long chain esters such as undecylenate limit
peak levels to bt 12 - 48 hours with the net effect often being higher peaks and lower troughs
And the latter is the reason Sustanon is rarely used in medical practice today.
Bottom line mixtures only serve to further complicate the endless unknowns of PEDS use IME.
I agree with most of what you said. However none of that translates to efficacy. Whether combining the two in one cycle, as a blend or not would be less or more advantageous to simply using one 19nor.
Define efficacy in this (your) context and how such an effect would be objectively quantified.
And any individual in their own n=1 could objectively quantify their results by experimenting with the two cyclesDefine efficacy in this (your) context and how such an effect would be objectively quantified.
And any individual in their own n=1 could objectively quantify their results by experimenting with the two cycles
